Virus-cell and cell-cell fusion

Annual Review of Cell and Developmental Biology

Volumn 12, Issue , 1996, Pages 627-661

  Hernandez, L D ^a,b   Hoffman, L R ^b   Wolfsberg, T G ^a,b,c   White, J M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ADAM; hemagglutinin; membrane fusion; myoblast; viral glycoprotein

Indexed keywords

CELL SURFACE PROTEIN; COMPLEMENTARY DNA; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ;

CELL FUSION; CONFORMATIONAL TRANSITION; FLAVIVIRUS; GAMETE; INFLUENZA VIRUS; MEMBRANE BINDING; MEMBRANE FUSION; MULTIGENE FAMILY; MYOBLAST; NONHUMAN; PARAMYXOVIRUS; PH; PRIORITY JOURNAL; PROTEIN CONFORMATION; RETROVIRUS; REVIEW; TOGAVIRUS; VIRUS CELL INTERACTION;

CELL MEMBRANE; MEMBRANE FUSION; RECOMBINANT FUSION PROTEINS; VIRAL FUSION PROTEINS; VIRUSES;

FLAVIVIRUS; INFLUENZA VIRUS; PARAMYXOVIRIDAE; TOGAVIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 0029770079     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.12.1.627     Document Type: Review

References (176)

1. Allison SL, Schalich J, Stiasny K, Mandl CW, Kunz C, Heinz FX. 1995. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J. Virol. 69:695-700
2. Almeida EAC, Huovila A-PJ, Sutherland AE, Stephens LE, Calarco PG, et al. 1995. Mouse egg integrin α6β1 functions as a sperm receptor. Cell 81:1095-104
3. Anthony RP, Brown DT. 1991. Protein-protein interactions in an alphavirus membrane. J. Virol. 65:1187-94
4. Bagai S, Lamb RA. 1995. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69:6712-19
5. Bates P, Young JAT, Varmus HE. 1993. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell 74:1043-51
6. Bentz J, ed. 1993. Viral Fusion Mechanisms. Boca Raton, FL: CRC Press. 529 pp.
7. Blobel CP, Wolfsberg TG, Turck CW, Myles DG, Primakoff P, White JM. 1992. A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356:248-52
8. Blumenthal R, Pak CC, Raviv Y, Krumbiegel M, Bergelson LD, et al. 1995. Transient domains induced by influenza haemagglutinin during membrane fusion. Mol. Membr. Biol. 12:135-42
9. Bousse T, Takimoto T, Gorman WL, Takahashi T, Portner A. 1994. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology 204:506-14
10. Brasseur R, Vandenbranden M, Cornet B, Burny A, Ruysschaert J-M. 1990. Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins. Biochim. Biophys. Acta 1029:267-73
11. Bron R, Wahlberg JM, Garoff H, Wilschut J. 1993. Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein. EMBO J. 12:693-701
12. Brown JC, Newcomb WW, Lawrenz-Smith S. 1988. pH-Dependent accumulation of the vesicular stomatitis virus glycoprotein at the ends of intact virions. Virology 167:625-29
13. Buckland R, Malvoisin E, Beauverger P, Wild F. 1992. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73:1703-7
14. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43
15. Cao J, Bergeron L, Helseth E, Thali M, Repke H, Sodroski J. 1993. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67:2747-55
16. Carr CM, Kim PS. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-32
17. Cavanagh D, Davis PJ, Darbyshire JH, Peters RW. 1986. Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. J. Gen. Virol. 67:1435-42
18. Chambers P, Pringle CR, Easton AJ. 1990. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:3075-80
19. Chen SS, Lee CN, Lee WR, McIntosh K, Lee TH. 1993. Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J. Virol. 67:3615-19
20. Cheng RH, Kuhn RJ, Olson NH, Rossman MG, Choi H-K, Baker TS. 1995. Nucleocapsid and glycoprotein organization in an enveloped virus. Cell 80:621-30
21. Chernomordik L, Kozlov MM, Zimmerberg J. 1995. Lipids in biological membrane fusion. J. Membr. Biol. 146:1-14
22. 2+-, GTP, and pH-dependent fusion of biological membranes. FEBS Lett. 318:71-76
23. Clague MJ, Schoch C, Blumenthal R. 1991. Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density. J. Virol. 65:2402-7
24. Clague MJ, Schoch C, Zech L, Blumenthal R. 1990. Gating kinetics of pH-activated membrane fusion of vesicular stomatitis virus with cells: stopped-flow measuremnts by dequenching of octadecylrhodamine fluorescence. Biochemistry 29:1303-8
25. Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schulz TF, et al. 1991. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res. Hum. Retroviruses 7:3-16
26. Daniel C, Anderson R, Buchmeier MJ, Fleming JO, Spaan WJ, et al. 1993. Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of a complex tridimensional structure. J. Virol. 67:1185-94
27. Danieli T, Pelletier SL, Henis YI, White JM. 1996. Membrane fusion mediated by the influenza hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 133:559-69
28. Delwart EL, Mosialos G, Gilmore T. 1990. Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat [comment]. AIDS Res. Hum. Retroviruses 6:703-6
29. Di Simone C, Buchmeier MJ. 1995. Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex. Virology 209:3-9
30. Doms RW. 1993. Protein conformational changes in virus-cell fusion. In Methods in Enzymology, ed. N Duzgunes, 221:61-82. San Diego: Academic
31. Doms RW, Blumenthal R, Moss B. 1990. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J. Virol. 64:4884-92
32. Doms RW, Helenius A. 1986. Quaternary structure of influenza virus hemagglutinin after acid treatment. J. Virol. 60:833-39
33. Dubay JW, Dubay SR, Shin HJ, Hunter E. 1995. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 69:4675-82
34. Dubay JW, Roberts SJ, Brody B, Hunter E. 1992a. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66:4748-56
35. Dubay JW, Roberts SJ, Hahn BH, Hunter E. 1992b. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66:6616-25
36. Durrer P, Gaudin Y, Ruigrok RWH, Graf R, Brunner J. 1995. Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses. J. Biol. Chem. 270:17575-81
37. Earl PL, Doms RW, Moss B. 1990. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 87:648-52
38. Einfeld D, Hunter E. 1988. Oligomeric structure of a prototypic retrovirus glycoprotein. Proc. Natl. Acad. Sci. USA 85:8688-92
39. Elion EA, Trueheart J, Fink GR. 1995. Fus2 localizes near the site of cell fusion and is required for both cell fusion and nuclear alignment during zygote formation. J. Cell Biol. 130:1283-96
40. Ellens H, Bentz J, Mason D, Zhang F, White JM. 1990. Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. Biochemistry 29:9697-707
41. Evans JP, Schultz RM, Kopf GS. 1995. Mouse sperm-egg plasma membrane interactions: analysis of roles of egg integrins and the mouse sperm homologue of PH-30 (fertilin) b. J. Cell Sci. 108:3267-78
42. Fantini J, Cook DG, Nathanson N, Spitalnik SL, Gonzalez-Scarano F. 1993. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. USA 90:2700-4
43. Feng Y, Broder CC, Kennedy PE, Berger EA. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872-77
44. Ferris PJ, Woessner JP, Goodenough UW. 1996. A sex recognition glycoprotein is encoded by the plus mating-type gene fus1 of Chlamydomonas reinhardtii. Mol. Biol. Cell. In press
45. Fredericksen BL, Whitt MA. 1995. Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity. J. Virol. 69:1435-43
46. Freed EO, Myers DJ, Risser R. 1990. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA 87:4650-54
47. Frey S, Marsh M. Gunther S, Pelchen-Matthews A, Stephens P, et al. 1995. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. J. Virol. 69:1462-72
48. Fuller SD, Berriman JA, Butcher SJ, Gowen BE. 1995. Low pH induces swiveling of the glycoprotein heterodimers in the Semliki Forest virus spike complex. Cell 81:715-25
49. Gage PJ, Levine M, Glorioso JC. 1993. Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. J. Virol. 67:2191-201
50. Gallagher TM, Escarmis C, Buchmeier MJ. 1991. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J. Virol. 65:1916-28
51. Gaudin Y, Ruigrok RWH, Brunner J. 1995. Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism. J. Gen. Virol. 76:1541-56
52. Gaudin Y, Ruigrok RWH, Knossow M, Flamand A. 1993. Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion. J. Virol. 67:1365-72
53. Gething M-J, Doms RW, York D, White JM. 1986. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J. Cell Biol. 102:11-23
54. Gilbert JM, Bates P, Varmus HE, White JM. 1994. The receptor for the subgroup A avian leukosis sarcoma virus binds to subgroup A but not to subgroup C envelope glycoprotein. J. Virol. 67:6889-92
55. Gilbert JM, Hernandez LD, Balliet JW, Bates P, White JM. 1995. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J. Virol. 69:7410-15
56. Gilbert JM, Mason D, White J. 1990. Fusion of Rous sarcoma virus with host cells does not require low pH. J. Virol. 64:5106-13
57. Glabe CG. 1985. Interaction of the sperm adhesive protein, bindin, with phospholipid vesicles. II. Bindin induces the fusion of mixed-phase vesicles that contain phosphatidylcholine and phosphatidylserine in vitro. J. Cell Biol. 100:800-6
58. Glushakova SE, Omelyanenko VG, Lukashevitch IS, Bogdanov AA, Moshnikova AB, et al. 1992. The fusion of artificial lipid membranes induced by the synthetic arenavirus 'fusion peptide'. Biochim. Biophys. Acta 1110:202-8
59. Godley L, Pfeifer J, Steinhauer D, Ely B, Shaw G, et al. 1992. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell 68:635-45
60. Gong SC, Lai CF, Esteban M. 1990. Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology 178:81-91
61. Gray C, Tatulian SA, Wharton SA, Tamm LK. 1996. Effect of the N-terminal glycine on the secondary structure, orientation and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers. Biophys. J. 70:2275-86
62. Guirakhoo F, Heinz FX, Mandl CW, Holzmann H, Kunz C. 1991. Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J. Gen. Virol. 72:1323-29
63. Gutman O, Danieli T, White JM, Henis YI. 1993. Effects of exposure to low pH on the lateral mobility of influenza hemagglutinin expressed at the cell surface. Biochemistry 32:101-6
64. Guy HR, Durell SR, Schoch C, Blumenthal R. 1992. Analyzing the fusion process of influenza hemagglutinin by mutagenesis and molecular modeling. Biophys. J. 62:95-97
65. Hacker JK, Volkman LE, Hardy JL. 1995. Requirement for the G1 protein of California encephalitis virus in infection in vitro and in vivo. Virology 206:945-53
66. Hart TK, Kirsh R, Ellens H, Sweet RW, Lambert DM, et al. 1991. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 88:2189-93
67. Harter C, James P, Bächi T, Semenza G, Brunner J. 1989. Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide." J. Biol. Chem. 264:6459-64
68. Helenius A. 1995. Alphavirus and flavivirus glycoproteins: structure and function. Cell 81:651-53
69. Helm CA, Israelachvili JN. 1993. Forces between phospholipid bilayers and relationship to membrane fusion. Meth. Enzymol. 220:130-43
70. Heminway BR, Yu Y, Tanaka Y, Perrine KG, Gustafson E, et al. 1994. Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion. Virology 200:801-5
71. Herold BC, Visalli RJ, Susmarski N, Brandt CR, Spear PG. 1994. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J. Gen. Virol. 75:1211-22
72. Hughson FM. 1995. Structural characterization of viral fusion proteins. Curr. Biol. 5:265-74
73. Hutchinson L, Roop-Beauchamp C, Johnson DC. 1995. Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface. J. Virol. 69:4556-63
74. Johnston PB, Dubay JW, Hunter E. 1993. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J. Virol 67:3077-86
75. Jones JS, Risser R. 1993. Cell fusion induced by the murine leukemia virus envelope glycoprotein. J. Virol. 67:67-74
76. Junankar PR, Cherry RJ. 1986. Temperature and pH dependence of the haemolytic activity of influenza virus and of the rotational mobility of the spike glycoproteins. Biochim. Biophys. Acta 854:198-206
77. Justman J, Klimjack MR, Kielian M. 1993. Role of spike protein conformational changes in fusion of Semliki Forest virus. J. Virol. 67:7597-607
78. Katow S, Sugiura A. 1988. Low pH-induced conformational change of Rubella virus envelope proteins. J. Gen. Virol. 69:2797-807
79. Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, et al. 1994. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA 91:7071-75
80. Kemble GW, Bodian DL, Rosé J, Wilson IA, White JM. 1992. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin. J. Virol. 66:4940-50
81. Kemble GW, Danieli T, White JM. 1994. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 76:383-91
82. Kielian M. 1995. Membrane fusion and the alphavirus life cycle. Adv. Vir. Res. 45:113-51
83. Kimura T, Ohyama A. 1988. Association between the pH-dependent conformational change of West Nile flavivirus E protein and virus-mediated membrane fusion. J. Gen. Virol. 69:1247-54
84. Klimjack MR, Jeffrey S, Kielian M. 1994. Membrane and protein interactions of a soluble form of the Semliki Forest virus fusion protein. J. Virol. 68:6940-46
85. Kurihara LJ, Beh CT, Latterich M, Schekman R, Rose M. 1994. Nuclear congression and membrane fusion: two distinct events in the yeast karyogamy pathway. J. Cell Biol. 126:911-23
86. Kuroki K, Cheung R, Marion PL, Ganem D. 1994. A cell surface protein that binds avian hepatitis B virus particles. J. Virol. 68:2091-96
87. LaBranche CC, Sauter MM, Haggarty BS, Vance PJ, Romano J, et al. 1994. Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus. J. Virol. 68:5509-22
88. Lamb RA. 1993. Paramyxovirus fusion: a hypothesis for change. Virology 197:1-11
89. Lanzrein M, Kasermann N, Weingart R, Kempf C. 1993. Early events of Semliki Forest virus-induced cell-cell fusion. Virology 196:541-47
90. Lear JD, DeGrado WF. 1987. Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. J. Biol. Chem. 262:6500-5
91. Levy-Mintz P, Kielian M. 1991. Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein. J. Virol. 65:4292-300
92. Lindau M, Almers W. 1995. Structure and function of fusion pores in exocytosis and ectoplasmic membrane fusion. Curr. Opin. Cell Biol. 7:509-17
93. Long D, Berson JF, Cook DG, Doms RW. 1994. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide. J. Virol. 68:5890-98
94. Lu M, Blacklow S, Kim PS. 1995. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1075-82
95. McClure MO, Sommerfelt MA, Marsh M, Weiss RA. 1990. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71:767-73
96. Melikyan GB, Niles WD, Cohen FS. 1993a. Influenza virus hemagglutinin-induced cell-planar bilayer fusion: quantitative dissection of fusion pore kinetics into stages. J. Gen. Physiol. 102:1131-46
97. Melikyan GB, Niles WD, Peeples ME, Cohen FS. 1993b. Influenza hemagglutinin-mediated fusion pores connecting cells to planar membranes: flickering to final expansion. J. Gen. Physiol. 102:1131-49
98. Melikyan GB, Niles WD, Ratinov VA, Karhanek M, Zimmerberg J, Cohen FS. 1995a. Comparison of transient and successful fusion pores connecting influenza hemagglutinin expressing cells to planar membranes. J. Gen. Physiol. 106:803-19
99. Melikyan GB, White JM, Cohen FS. 1995b. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J. Cell Biol. 131:679-91
100. Meyer WJ, Gidwitz S, Ayers VK, Schoepp RJ, Johnston RE. 1992. Conformational alteration of sindbis virion glycoproteins induced by heat, reducing agents, or low pH. J. Virol. 66:3504-13
101. Moesby L, Corver J, Erukulla RK, Bittman R, Wilschut J. 1995. Sphingolipids activate membrane fusion of Semliki Forest virus in a stereospecific manner. Biochemistry 34:10319-24
102. Monck JR, Fernandez JM. 1994. The exocytic fusion pore and neurotransmitter release. Neuron 12:707-16
103. Moore JP, McKeating JA, Huang YX, Ashkenazi A, Ho DD. 1992. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J. Virol. 66:235-43
104. Moore JP, McKeating JA, Weiss RA, Sattentau QJ. 1990. Dissociation of gp120 from HIV-1 virions induced by soluble CD4 [see comments]. Science 250:1139-42
105. Morris S, Sarkar D, White J, Blumenthal R. 1989. Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. Measurement by dequenching of fluorescence. J. Biol. Chem. 264:3972-78
106. Morrison T, McQuain C, McGinnes L. 1991. Complementation between avirulent New-castle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J. Virol. 65:813-22
107. Muga A, Neugebauer W, Hirama T, Surewicz WK. 1994. Membrane interactive and conformational properties of the putative fusion peptide of PH-30, a protein active in sperm-egg fusion. Biochemistry 33:4444-48
108. Mulligan MJ, Yamshchikov GV, Ritter GD Jr, Gao F, Jin MJ, et al. 1992. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:3971-75
109. Myles DG, Kimmel LH, Blobel CP, White JM, Primakoff P. 1994. Identification of a binding site in the disintegrin domain of fertilin required for sperm-egg fusion. Proc. Natl. Acad. Sci. USA 91:4195-98
110. Nanavati C, Markin VS, Oberhauser AF, Fernandez JM. 1992. The exocytic fusion pore modeled as a lipidic pore. Biophys. J. 63:1118-32
111. Nieva JL, Bron R, Corver J, Wilschut J. 1994a. Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J. 13:2797-804
112. Nieva JL, Nir S, Muga A, Goni FM, Wilschut J. 1994b. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage. Biochemistry 33:3201-9
113. Owens RJ, Burke C, Rose JK. 1994. Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity. J. Virol. 68:570-74
114. Pak CC, Krumbiegel M, Blumenthal R. 1994. Intermediates in influenza virus PR/8 haemagglutinin-induced membrane fusion. J. Gen. Virol. 75:395-99
115. Paredes AM, Brown DT, Rothnagel R, Chiu W, Schoepp RJ, et al. 1993. Three-dimensional structure of a membrane-containing virus. Proc. Natl. Acad. Sci. USA 90:9095-99
116. Pekosz A, Griot C, Nathanson N, Gonzalez-Scarano F. 1995. Tropism of bunyaviruses: evidence for a G1 glycoprotein-mediated entry pathway common to the California serogroup. Virology 214:339-48
117. Podbilewicz B, White JG. 1994. Cell fusion in the developing epithelial of C. elegans. Dev. Biol 161:408-24
118. Primakoff P, Hyatt H, Tredick-Kline J. 1987. Identification and purification of a sperm surface protein with a potential role in sperm-egg membrane fusion. J. Cell Biol. 104:141-49
119. Purchase H, Okazaki W. 1964. Morphology of foci produced by standard preparations of Rous sarcoma virus. J. Natl. Cancer Inst. 32:579-84
120. Ragheb JA, Anderson WF. 1994. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68:3220-31
121. Rein A, Mirro J, Haynes JG, Ernst SM, Nagashima K. 1994. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68:1773-81
122. Reitter JN, Sergel T, Morrison TG. 1995. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69:5995-6004
123. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291-98
124. r envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J. Virol. 61:395-404
125. Rodriguez-Crespo I, Nunez E, Gomez-Gutierrez J, Yelamos B, Albar JP, et al. 1995. Phospholipid interactions of the putative fusion peptide of hepatitis B virus surface antigen S protein. J. Gen. Virol. 76:301-8
126. Roehrig JT, Johnson AJ, Hunt AR, Bolin RA, Chu MC. 1990. Antibodies to dengue 2 virus E glycoprotein synthetic peptides identify antigenic conformation. Virology 177:668-75
127. Ronka H, Hilden P, von Bonsdorff C-H, Kuismanen E. 1995. Homodimeric association of the spike glycoprotein G1 and G2 of Uukuniemi virus. Virology 211:241-50
128. Roop C, Hutchinson L, Johnson DC. 1993. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J. Virol. 67:2285-97
129. Rothman JE, Warren G. 1994. Implications of the SNARE hypothesis for intracellular membrane topology and dynamics. Curr. Biol. 4:220-33
130. Ruigrok RWH, Aitken A, Calder LJ, Martin SR, Skehel JJ, et al. 1988. Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J. Gen. Virol. 69:2785-95
131. Saginario C, Qian H-Y, Vignery A. 1995. Identification of an inducible surface molecule specific to fusing macrophges. Proc. Natl. Acad. Sci. USA 92:12210-14
132. Sattentau QJ, Moore JP. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-15
133. Sattentau QJ, Moore JP, Vignaux F, Traincard F, Poignard P. 1993. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67:7383-93
134. Sauter MM, Pelchen-Matthews A, Bron R, Marsh M, LaBranche C, et al. 1996. An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. J. Cell Biol. 132:795-811
135. Sergel-Germano T, McQuain C, Morrison T. 1994. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68:7654-58
136. Siegel DP. 1993. Energetics of intermediates in membrane fusion: comparison of stalk and inverted micellar intermediate mechanisms. Biophys. J. 65:2124-40
137. Spear PG. 1993. Entry of alphaherpesviruses into cells (?). Semin. Virol. 4:167-80
138. Spies CP, Ritter GD Jr, Mulligan MJ, Compans RW. 1994. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J. Virol. 68:585-91
139. Spruce AE, Iwata A, Almers W. 1991. The first milliseconds of the pore formed by a fusogenic viral envelope protein during membrane fusion. Proc. Natl. Acad. Sci. USA 88:3623-27
140. Spruce AE, Iwata A, White JM, Almers W. 1989. Patch clamp studies of single cell-fusion events mediated by a viral fusion protein. Nature 342:555-58
141. Stegmann T. 1993. Influenza hemagglutinin-mediated membrane fusion does not involve inverted phase lipid intermediates. J. Biol. Chem. 268:1716-22
142. Stegmann T. 1994. Anchors aweigh. Curr. Biol. 4:551-54
143. Stegmann T, White JM, Helenius A. 1990. Intermediates in influenza-induced membrane fusion. EMBO J. 9:4231-41
144. Steinhauer DA, Wharton SA, Skehel JJ, Wiley DC. 1995. Studies of membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J. Virol. 69:6643-51
145. Stern W, Dales S. 1976. Biogenesis of vaccinia: isolation and characterization of a surface component that elicits antibody suppressing infectivity and cell-cell fusion. Virology 75:232-41
146. Sturman LS, Ricard CS, Holmes KV. 1990. Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37°C correlates with virus aggregation and virus-induced cell fusion. J. Virol. 64:3042-50
147. r 18,000 protein localized to the acrosomal region of acrosome-reacted abalone spermatozoa. Biochemistry 34:14202-8
148. Tatulian SA, Hinterdorfer P, Baber G, Tamm LK. 1995. Influenza hemagglutinin assumes a tilted conformation during membrane fusion as determined by attenuated total reflection FTIR spectroscopy. EMBO J. 14:5514-23
149. Tong S, Li J, Wands JR. 1995. Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection. J. Virol. 69:7106-12
150. Trueheart J, Fink GR. 1989. The yeast cell fusion protein FUS1 is O-glycosylated and spans the plasma membrane. Proc. Natl. Acad. Sci. USA 86:9916-20
151. Tse FW, Iwata A, Almers W. 1993. Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion. J. Cell Biol. 121:543-52
152. Tsurudome M, Glück R, Graf R, Falchetto R, Schaller U, Brunner J. 1992. Lipid interactions of the hemagglutinin HA2 NH-2-terminal segment during influenza virus-induced membrane fusion. J. Biol. Chem. 267:20225-32
153. Wahlberg JM, Bron R, Wilschut J, Garoff H. 1992. Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein. J. Virol. 66:7309-18
154. Wahlberg JM, Garoff H. 1992. Membrane fusion process of Semliki Forest virus I: low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells. J. Cell Biol. 116:339-48
155. Ward CD, Paterson RG, Lamb RA. 1995. Mutants of the paramyxovirus SV5 fusion protein: regulated and extensive syncytium formation. Virology 209:242-49
156. Ward CW, Dopheide TA. 1980. Influenza virus haemagglutinin. Structural predictions suggest that the fibrillar appearance is due to the presence of a coiled-coil. Aust. J. Biol. Sci. 33:449-55
157. +-induced insertion of the influenza hemagglutinin HA2 N-terminal segment into the viral membrane. J. Biol. Chem. 269:18353-58
158. Weiss CD, Levy JA, White JM. 1990. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J. Virol. 64:5674-77
159. Weiss R. 1992. Cellular receptors and viral glycoproteins involved in retrovirus entry. In The Retroviruses, ed. J Levy. 2:1-108. New York: Plenum
160. Wharton SA, Calder LJ, Ruigrok RWH, Skehel JJ, Steinhauer DA, Wiley DC. 1995. Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J. 14:240-46
161. White JM. 1992. Membrane fusion. Science 258:917-24
162. White JM. 1995. Membrane fusion: the influenza paradigm. Cold Spring Harbor Symp. Quant. Biol. 60:581-88
163. Wild C, Dubay JW, Greenwell T, Baird T Jr, Oas TG, et al. 1994a. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA 91:12676-80
164. Wild CT, Shugars DC, Greenwell TK, McDanal CB, Matthews TJ. 1994b. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91:9770-74
165. Wiley DC, Skehel JJ. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:365-94
166. Wilson CA, Marsh JW, Eiden MV. 1992. The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus. J. Virol. 66:7262-69
167. Wilson IA, Skehel JJ, Wiley DC. 1981. Structure of the haemagglutinin membrane glycoportein of influenza virus at 3Å resolution. Nature 289:366-72
168. Wimmer E, ed. 1994. Cellular Receptors for Animal Viruses, pp. 403-43. Plainview, NY: Cold Spring Harbor Lab. Press
169. Wolfsberg TG, Primakoff P, Myles DG, White JM. 1995. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 131:275-78
170. Yagami-Hiromasa T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y, Fujisawa-Sehara A. 1995. A metalloprotease-disintegrin participating in myoblast fusion. Nature 377:652-56
171. Yang C, Compans RW. 1996. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide. J. Virol. 70:248-54
172. Yu YG, King DMS, Shin Y-K. 1994. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science 266:274-76
173. Zagouras P, Rose JK. 1993. Dynamic equilibrium between vesicular stomatitis virus glycoprotein monomers and trimers in the Golgi and at the cell surface. J. Virol. 67:7533-38
174. Zhang L, Ghosh HP. 1994. Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G. J. Virol. 68:2186-93
175. Zimmerberg J, Blumenthal R, Sarkar DP, Curran M, Morris SJ. 1994. Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion. J. Cell Biol. 127:1885-94
176. Zingler K, Littman DR. 1993. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity. J. Virol. 67:2824-31